APA
Weisner J., Landel I., Reintjes C., Uhlenbrock N., Trajkovic-Arsic M., Dienstbier N., Hardick J., Ladigan S., Lindemann M., Smith S., Quambusch L., Scheinpflug R., Depta L., Gontla R., Unger A., Müller H., Baumann M., Schultz-Fademrecht C., Günther G., Maghnouj A., Müller M. P., Pohl M., Teschendorf C., Wolters H., Viebahn R., Tannapfel A., Uhl W., Hengstler J. G., Hahn S. A., Siveke J. T. & Rauh D. (20200207). Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in. : Cancer research.
Chicago
Weisner Jörn, Landel Ina, Reintjes Christoph, Uhlenbrock Niklas, Trajkovic-Arsic Marija, Dienstbier Niklas, Hardick Julia, Ladigan Swetlana, Lindemann Marius, Smith Steven, Quambusch Lena, Scheinpflug Rebekka, Depta Laura, Gontla Rajesh, Unger Anke, Müller Heiko, Baumann Matthias, Schultz-Fademrecht Carsten, Günther Georgia, Maghnouj Abdelouahid, Müller Matthias P, Pohl Michael, Teschendorf Christian, Wolters Heiner, Viebahn Richard, Tannapfel Andrea, Uhl Waldemar, Hengstler Jan G, Hahn Stephan A, Siveke Jens T and Rauh Daniel. 20200207. Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in. : Cancer research.
Harvard
Weisner J., Landel I., Reintjes C., Uhlenbrock N., Trajkovic-Arsic M., Dienstbier N., Hardick J., Ladigan S., Lindemann M., Smith S., Quambusch L., Scheinpflug R., Depta L., Gontla R., Unger A., Müller H., Baumann M., Schultz-Fademrecht C., Günther G., Maghnouj A., Müller M. P., Pohl M., Teschendorf C., Wolters H., Viebahn R., Tannapfel A., Uhl W., Hengstler J. G., Hahn S. A., Siveke J. T. and Rauh D. (20200207). Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in. : Cancer research.
MLA
Weisner Jörn, Landel Ina, Reintjes Christoph, Uhlenbrock Niklas, Trajkovic-Arsic Marija, Dienstbier Niklas, Hardick Julia, Ladigan Swetlana, Lindemann Marius, Smith Steven, Quambusch Lena, Scheinpflug Rebekka, Depta Laura, Gontla Rajesh, Unger Anke, Müller Heiko, Baumann Matthias, Schultz-Fademrecht Carsten, Günther Georgia, Maghnouj Abdelouahid, Müller Matthias P, Pohl Michael, Teschendorf Christian, Wolters Heiner, Viebahn Richard, Tannapfel Andrea, Uhl Waldemar, Hengstler Jan G, Hahn Stephan A, Siveke Jens T and Rauh Daniel. Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in. : Cancer research. 20200207.